Q2 2026 saw the launch of the first consumer product using proprietary aerogel technology and the introduction of the Naerogel® platform. Net sales declined year-over-year, but a fully subscribed rights issue strengthened liquidity for future commercialization and growth.Original document: Svenska…
Net sales grew 9.2% year-over-year in Q2 2026, driven by all business areas and strategic acquisitions. Adjusted operating margin was 5.8%, with free cash flow impacted by the KNXT acquisition. Market momentum is strong, especially in Sweden and the US.Original document: Studsvik AB [SVIK] Slides R…
Sales grew 8.5% year-over-year in Q2 2026, driven by all business areas, but operating profit declined due to acquisition costs and strategic investments. The acquisition of Kärnfull Next AB broadens the new build offering, while continued innovation and expansion in nuclear projects position the c…
Service and equipment revenues grew strongly in H1 2026, with EBITDA exceeding EUR 100 million and margins above 40%. Market share leadership was maintained across key segments, and a record dividend was paid. Share price rose 15.34% in H1 2026.Original document: Telia Lietuva AB [TEL1L] Slides Rel…
Net sales grew 6.8% in Q2 and 2.6% in H1 2026, with positive EBITDA in Q2 but a loss for H1. PrivX PAM drove growth, liquidity improved after hybrid loan repurchase, and recurring revenue ARR rose 5.4%. Outlook for 2026 remains positive.Original document: SSH Communications Security Oyj [SSH1V] Int…
Revenue and EBITDA saw strong year-over-year growth in H1 2026, driven by mobile and IT services, with significant investments in 5G spectrum and network expansion. Free cash flow and profit rose, supporting a record dividend payout, while the company maintained a net cash position.Original documen…
Record-high quarterly sales and profit were achieved, driven by acquisitions and strong green OEM demand, with EBITA and EPS both up 5% year-over-year. Cash flow remained stable, and the acquisition pipeline is robust, supporting continued growth.Original document: Beijer Ref AB Class B [BEIJ_B] In…
EBITDA excluding special items surged 39% year-over-year to USD 906 million in Q2 2026, driven by higher margins and cost discipline, while net income rose to USD 545 million. The acquisition of Gulf Coast Ammonia strengthens the ammonia and energy strategy amid ongoing market volatility.Original d…
Net sales and profitability improved across all segments in H1 2026, with Adjusted EBITDA up 10.2% and free cash flow up 46% year-over-year. The company completed a major organizational transformation, divested Emaileri Oy, and acquired Eivora AB, while maintaining a strong balance sheet and updati…
Net revenue grew 3% in Q2 2026, with adjusted operating profit up 6% and improved profitability in Sweden and Finland. Free cash flow more than doubled, while a public takeover bid was announced and recommended by the board.Original document: Humana AB [HUM] Interim report — Jul. 17 2026This is an…
Revenue and profit grew strongly in Q2 2026, with adjusted EBITA margin up to 7.2% and cash flow from operations more than doubling year-over-year. Sweden and Finland showed solid organic growth, while Norway faced headwinds in oil and gas. Dividend was raised to SEK 2.20 per share.Original documen…
Q2 2026 saw improved margins and profitability, with net sales up slightly and strong growth in own consumer brands. The Risenta acquisition and insurance compensation boosted results, while cost control and efficiency gains supported higher operating margins.Original document: Midsona AB Class A…
Net sales grew 1% year-over-year in Q2 2026, with stable gross margins and EBITA, but EBIT and net profit were heavily impacted by a MSEK 600 non-cash goodwill impairment in Sustainable Care. Strategic divestments and investments continued, and leverage increased to 2.8x.Original document: Humble G…
Organic sales and order intake grew strongly in Q2 2026, with profitability and cash flow significantly improved by operational gains and a major tariff refund. Acute Care Therapies and Life Science segments led growth, while APAC lagged. Outlook for 2026 remains positive despite ongoing geopolitic…
Q2 2026 saw 3% sales growth and a 9% EBIT increase, with strong cash flow and margin expansion. Five acquisitions and one divestment were completed, while organic growth was robust in EMEIA and Americas but declined in Asia Pacific. Guidance anticipates continued acquisition-driven growth but margi…
Order intake grew 1% year-over-year, while revenue declined 2% and adjusted EBITA margin fell to 17.2%. Wind and Height Safety segments showed strong growth, but Construction and Facade Access faced headwinds. The Pro-Bel acquisition and refinancing strengthen future positioning.Original document…
Revenue and gross profit were stable in H1 2026, with Influencer Marketing showing double-digit growth and Partner Marketing declining. Restructuring improved efficiency, and the company strengthened its net cash position while launching new business areas and completing a rebranding.Original docum…
Net sales and profit declined sharply in Q2 2026 due to the 'Sell first, pay later' rollout and lower listing volumes, though ARPL rose 12.4% and B2B revenue remained stable. Management expects deferred revenue to be realized in future periods as the property market gradually recovers.Original docu…
Net sales declined 13.3% year-over-year due to currency headwinds and lower instrument sales, but gross margin improved to 40.9% on a favorable product mix. Veterinary and OEM segments showed resilience, and the company expects improved sales in the second half of 2026.Original document: Boule Diag…
Net sales and earnings declined sharply in Q2 and H1 2026 due to weak demand and cautious market conditions, with all regions reporting negative growth. Despite cost reductions and a positive launch of the Profoto ProPanel, profitability and key financial ratios deteriorated year-over-year.Original…
